Header Logo

Tasneem Bawa-Khalfe

TitleAssociate Professor
InstitutionUniversity of Houston
DepartmentBiology and Biochemistry
Address4800 Calhoun Rd
Houston TX 77004
Phone713-743-4288
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01CA256543     (BAWA-KHALFE, TASNEEM)Sep 1, 2021 - Jun 30, 2026
    NIH
    Targeting Constitutively Active SUMO Modified Androgen Receptors in Endocrine Resistant Breast Cancer
    Role: Principal Investigator
    F32CA110620     (BAWA-KHALFE, TASNEEM)Sep 1, 2006 - Aug 31, 2008
    NIH
    Role of SENP1 in Prostate Cancer Pathogenesis
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Abdulkareem NM, Bhat R, Castillo M, Jung SY, Vasaikar S, Nanda S, Ruiz A, Shea M, Cao W, Veeraraghavan J, Kim HY, Bawa-Khalfe T, Hussain T, Liu X, Gunaratne P, Schiff R, Trivedi MV. Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2-positive breast cancer. Br J Pharmacol. 2025 Feb 18. PMID: 39965212.
      Citations:    Fields:    
    2. Palacios AV, Acharya P, Peidl AS, Beck MR, Blanco E, Mishra A, Bawa-Khalfe T, Pakhrin SC. SumoPred-PLM: human SUMOylation and SUMO2/3 sites Prediction using Pre-trained Protein Language Model. NAR Genom Bioinform. 2024 Mar; 6(1):lqae011. PMID: 38327870; PMCID: PMC10849187.
      Citations: 1     
    3. Khan AF, Karami S, Peidl AS, Waiters KD, Babajide MF, Bawa-Khalfe T. Androgen Receptor in Hormone Receptor-Positive Breast Cancer. Int J Mol Sci. 2023 Dec 29; 25(1). PMID: 38203649; PMCID: PMC10779387.
      Citations: 1     Fields:    Translation:Humans
    4. Quttina M, Waiters KD, Khan AF, Karami S, Peidl AS, Babajide MF, Pennington J, Merchant FA, Bawa-Khalfe T. Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer. Cells. 2023 10 20; 12(20). PMID: 37887339; PMCID: PMC10605189.
      Citations: 1     Fields:    Translation:HumansCells
    5. Premaratne A, Ho C, Basu S, Khan AF, Bawa-Khalfe T, Lin CY. Liver X Receptor Inverse Agonist GAC0001E5 Impedes Glutaminolysis and Disrupts Redox Homeostasis in Breast Cancer Cells. Biomolecules. 2023 02 10; 13(2). PMID: 36830714; PMCID: PMC9953168.
      Citations:    Fields:    Translation:HumansCells
    6. Bahnassy S, Thangavel H, Quttina M, Khan AF, Dhanyalayam D, Ritho J, Karami S, Ren J, Bawa-Khalfe T. Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer. Cell Commun Signal. 2020 09 18; 18(1):154. PMID: 32948192; PMCID: PMC7501670.
      Citations: 6     Fields:    Translation:HumansCells
    7. Faria M, Karami S, Granados-Principal S, Dey P, Verma A, Choi DS, Elemento O, Bawa-Khalfe T, Chang JC, Strom AM, Gustafsson J?. The ER?4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ER? variants ER?2 and ER?5 increase aggressiveness of TNBC by regulation of hypoxic signaling. Oncotarget. 2018 Feb 23; 9(15):12201-12211. PMID: 29552303; PMCID: PMC5844739.
      Citations: 6     Fields:    
    8. Karami S, Lin FM, Kumar S, Bahnassy S, Thangavel H, Quttina M, Li Y, Ren J, Bawa-Khalfe T. Novel SUMO-Protease SENP7S Regulates ?-catenin Signaling and Mammary Epithelial Cell Transformation. Sci Rep. 2017 04 21; 7:46477. PMID: 28429743; PMCID: PMC5399363.
      Citations: 11     Fields:    Translation:HumansCells
    9. Bawa-Khalfe T, Yang FM, Ritho J, Lin HK, Cheng J, Yeh ET. SENP1 regulates PTEN stability to dictate prostate cancer development. Oncotarget. 2017 Mar 14; 8(11):17651-17664. PMID: 27852060; PMCID: PMC5392276.
      Citations: 24     Fields:    Translation:HumansAnimals
    10. Lin FM, Kumar S, Ren J, Karami S, Bahnassy S, Li Y, Zheng X, Wang J, Bawa-Khalfe T. SUMOylation of HP1a supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapy. Oncotarget. 2016 May 24; 7(21):30336-49. PMID: 27107417; PMCID: PMC5058684.
      Citations: 7     Fields:    Translation:HumansCells
    11. Huang C, Cheng J, Bawa-Khalfe T, Yao X, Chin YE, Yeh ETH. SUMOylated ORC2 Recruits a Histone Demethylase to Regulate Centromeric Histone Modification and Genomic Stability. Cell Rep. 2016 Apr 05; 15(1):147-157. PMID: 27052177.
      Citations: 23     Fields:    Translation:HumansCells
    12. Bawa-Khalfe T. Isolation of In Vivo SUMOylated Chromatin-Bound Proteins. Methods Mol Biol. 2016; 1475:205-16. PMID: 27631808.
      Citations: 4     Fields:    Translation:HumansCells
    Bawa-Khalfe's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (81)
    Explore
    _
    Co-Authors (6)
    Explore
    _
    Similar People (59)
    Explore
    _
    Same Department Expand Description
    Explore
    _